Filter by

Location

more »

Company

more »

We've found 72 jobs for you

LumaBio Partners  •  2026-04-19
  London, UK

Senior Clinical Trial Manager

Company OverviewWe are supporting a late clinical stage biopharmaceutical company advancing a first-in-class treatment of serious metabolic liver disease. Their lead programme is entering Phase 3, a significant inflection point for both the asset and the organ…

LumaBio Partners  •  2026-04-19
  Manchester, UK

Senior Clinical Trial Manager

Company OverviewWe are supporting a late clinical stage biopharmaceutical company advancing a first-in-class treatment of serious metabolic liver disease. Their lead programme is entering Phase 3, a significant inflection point for both the asset and the organ…

LumaBio Partners  •  2026-04-19
  Bristol, UK

Senior Clinical Trial Manager

Company OverviewWe are supporting a late clinical stage biopharmaceutical company advancing a first-in-class treatment of serious metabolic liver disease. Their lead programme is entering Phase 3, a significant inflection point for both the asset and the organ…

LumaBio Partners  •  2026-04-19
  Birmingham, UK

Senior Clinical Trial Manager

Company OverviewWe are supporting a late clinical stage biopharmaceutical company advancing a first-in-class treatment of serious metabolic liver disease. Their lead programme is entering Phase 3, a significant inflection point for both the asset and the organ…

LumaBio Partners  •  2026-04-19
  Leeds, UK

Senior Clinical Trial Manager

Company OverviewWe are supporting a late clinical stage biopharmaceutical company advancing a first-in-class treatment of serious metabolic liver disease. Their lead programme is entering Phase 3, a significant inflection point for both the asset and the organ…

LumaBio Partners  •  2026-04-19
  Glasgow, UK

Senior Clinical Trial Manager

Company OverviewWe are supporting a late clinical stage biopharmaceutical company advancing a first-in-class treatment of serious metabolic liver disease. Their lead programme is entering Phase 3, a significant inflection point for both the asset and the organ…

LumaBio Partners  •  2026-04-19
  Edinburgh, UK

Senior Clinical Trial Manager

Company OverviewWe are supporting a late clinical stage biopharmaceutical company advancing a first-in-class treatment of serious metabolic liver disease. Their lead programme is entering Phase 3, a significant inflection point for both the asset and the organ…

LumaBio Partners  •  2026-04-19
  Reading, UK

Senior Clinical Trial Manager

Company OverviewWe are supporting a late clinical stage biopharmaceutical company advancing a first-in-class treatment of serious metabolic liver disease. Their lead programme is entering Phase 3, a significant inflection point for both the asset and the organ…

LumaBio Partners  •  2026-04-19
  Cambridge, UK

Senior Clinical Trial Manager

Company OverviewWe are supporting a late clinical stage biopharmaceutical company advancing a first-in-class treatment of serious metabolic liver disease. Their lead programme is entering Phase 3, a significant inflection point for both the asset and the organ…

LumaBio Partners  •  2026-04-19
  Liverpool, UK

Senior Clinical Trial Manager

Company OverviewWe are supporting a late clinical stage biopharmaceutical company advancing a first-in-class treatment of serious metabolic liver disease. Their lead programme is entering Phase 3, a significant inflection point for both the asset and the organ…